R&D Systems™ Recombinant Human Integrin alpha 3 beta 1/VLA-3 Protein

Catalog No.	Quantity
2840A3050	50 μg

Catalog No. 2840A3050 Supplier R&D Systems™ Supplier No. 2840A3050

Description

Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity

The Recombinant Human Integrin alpha 3 beta 1/VLA-3 Protein is derived from CHO. The Recombinant Human Integrin alpha 3 beta 1/VLA-3 Protein has been validated for the following applications: Binding Activity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in Tris-Citrate and NaCl.
• Gene ID (Entrez): 3675
• Molecular Weight (g/mol): Observed Molecular Wt: 150kDa and 125kDa, reducing conditions, Predicted Molecular Wt.: 110.5kDa (Integrin alpha 3), 82.3kDa (Integrin beta 1)
• Name: Integrin alpha 3 beta 1/VLA-3
• Quantity: 50 μg
• Source: Chinese Hamster Ovary cell line,CHO-derived human Integrin alpha 3 beta 1/VLA-3 protein, (N-terminus) Human Integrin alpha 3 (Phe33-Glu991) Accession &Num; P26006 acidic tail Human Integrin beta 1 (Glu21-Asp728) Accession &Num; P05556 basic tail (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.1 EU per 1μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 90%, by SDS-PAGE under reducing conditions and visualized by silver stain.